• 1
    van Hillegersberg R, Kort WJ, Paul Wilson JH. Current status of photodynamic therapy in oncology. Drugs 1994;48: 51027.
  • 2
    Bonnet R. Photodynamic therapy in historical perspectives. Rev Contemp Pharmacother 1999;10: 117.
  • 3
    Sibata CH, Colussi VC, Oleinick NL, et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res 2000;33: 86980.
  • 4
    Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy review. J Natl Cancer Inst 1998;90: 889905.
  • 5
    Foultier MT, Vonarx-Coinsmann V, Cordel S, et al. Modulation of colonic cancer cell adhesiveness by haematoporphyrin derivative photodynamic therapy. J Photochem Photobiol B 1994;23: 917.
  • 6
    Rousset N, Vonarx V, Eleouet S, et al. Effects of photodynamic therapy on adhesion molecules and metastasis. J Photochem Photobiol B 1999;52: 6573.
  • 7
    Chen WR, Zhu WG, Dynlacht JR, et al. Long-term tumor resistance induced by laser photo-immunotherapy. Int J Cancer 1999;81: 80812.
  • 8
    Hendrzak-Henion JA, Knisely TL, Cincotta L, et al. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem Photobiol 1999;69: 57581.
  • 9
    Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 1999;59: 19416.
  • 10
    de Vree WJ, Essers MC, de Bruijn HS, et al. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer-Res 1996;56: 290811.
  • 11
    de Vree WJ, Essers MC, Koster JF, et al. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res 1997;57: 25558.
  • 12
    Gomer CJ, Ferrario A, Murphree AL. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer 1987;56: 2732.
  • 13
    Momma T, Hamblin MR, Wu HC, et al. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res 1998;58: 542531.
  • 14
    Scherz A, Salomon Y, Fiedor L. Catalytic condensation of chlorophyll and bactheriochlorophyll derivatives. US patent #5955:585, 1998.
  • 15
    Scherz A, Salomon Y, Brandis A, et al. Palladium-substituted bacteriochlorophyll derivatives and use thereof. International PCT Patent Application: No. PCT/IL99/00673, 1999.
  • 16
    Rosenbach-Belkin V, Chen L, Fiedor L, et al. Serine conjugates of Chlorophyll and Bacteriochlorophyll photocytotoxicity in vitro and tissue distribution in mice bearing Melanoma tumors. Photochem Photobiol 1996;64: 17481.
  • 17
    Rosenbach-Belkin V, Chen L, Fiedor L, et al. Photodynamic tumor therapy, 2nd and 3rd generation photosensitizers. In: MoserJ, ed. London: Harwood Academic Publishers, 1998. 11726.
  • 18
    Zilberstein J, Scherz A, Bromberg A, et al. Mechanisms involved in chlorophyll based photoinduced cell damage: photodynamic therapy of melanoma. Meeting of the Society of Magnetic Resonance. Nice, France, 1995;3: 1681.
  • 19
    Zilberstein J, Scherz A, Bromberg A, et al. The effects of Bacteriochlorophyll based PDT on tumor vasculature. Meeting of the Society of Magnetic Resonance. New York, 1996.
  • 20
    Zilberstein J, Schreiber S, Bloemers MCWM, et al. Anti-vascular treatment of solid melanoma tumors with bacteriochlorophyll-serine based photodynamic therapy. Photochem Photobiol 2001;73: 25763.
  • 21
    Kelleher DK, Thews O, Rzeznik J, et al. Water-filtered infrared-A radiation: a novel technique for localized hyperthermia in combination with bacteriochlorophyll-based photodynamic therapy. Int J Hyperthermia 1999;15: 46774.
  • 22
    Koudinova N, Pinthus JH, Brandis A, et al. Curative and palliative effects of a novel photodynamic agent (Pd bacteriopheophorbide) on prostate cancer: in vivo studies Using human prostate cancer xenografts. CapCURE 8th Annual Scientific Retreat. Lake Tahoe Nevada, 2001,
  • 23
    Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999;5: 124955.
  • 24
    Ben-Eliyahu S, Page GG, Yirmiya R, et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80: 8808.
  • 25
    Lundy J, Lovett EJD, Hamilton S, et al. Halothane, surgery, immunosuppression and artificial pulmonary metastases. Cancer 1978;41: 82730.
  • 26
    O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, et al. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 1999;274: 2956871.
  • 27
    Rivas MJ, Arii S, Furutani M, et al. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance. Hepatology 1998;28: 98693.
  • 28
    Yoon SS, Eto H, Lin CM, et al. Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 1999;59: 62516.
  • 29
    O'Reilly MS, Pirie-Shepherd S, Lane WS, et al. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999;285: 19268.
  • 30
    Hahnfeldt P, Panigrahy D, Folkman J, et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response and postvascular dormancy. Cancer Res 1999;59: 47705.
  • 31
    Wen W, Moses MA, Wiederschain D, et al. The generation of endostatin is mediated by elastase. Cancer Res 1999;59: 60526.
  • 32
    Ramsay J, Zietman A, Preffer F, et al. The growth and cell kinetics of a secondary tumor after radiation or surgical treatment of the primary tumor. Int J Radiat Oncol Biol Phys 1989;17: 80913.
  • 33
    Hartford AC, Gohongi T, Fukumura D, et al. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res 2000;60: 212831.